University Hospital and New Jersey Medical School (NJMS) are, through their joint FDA-approved convalescent plasma program, collecting plasma donations from patients who have recovered from COVID-19 and infusing it into patients still struggling to fight off the virus. Marc Klapholz, chair of NJMS” Department of Medicine and the hospital’s chief of medical service, explains that the presumed antibodies in the plasma may improve seriously ill patients’ chances for survival. To read the full article.
Recent Posts
- Rutgers drops longstanding COVID-19 vaccine policy for students, faculty.
- AI at Princeton: Pushing limits, accelerating discovery and serving humanity.
- Health How Medicines Are Making the Planet Sick.
- NJ ACTS BERD Workshop on 4/25 at 12pm
- Leprosy cases are rising in the US – what is the ancient disease and why is it spreading now?